Both in Pharmaceuticals
NewAmsterdam Pharma Company N.V vs Immunome
Over the past year NAMS returned −43.7% and IMNM returned +10.8%; their daily moves had a correlation of 0.35.
NAMS −43.7% IMNM +10.8%Growth of $1, one year, split-adjusted
| Metric | NAMS | IMNM |
|---|---|---|
| Price | $20.84 | $18.84 |
| Market cap | $2.49B | $2.22B |
| Today | +4.70% | −7.25% |
| 1 month | −6.4% | −2.4% |
| 6 months | −32.8% | −19.0% |
| Year to date | −40.6% | −12.3% |
| 1 year | −43.7% | +10.8% |
| Revenue growth (YoY) | −80.7% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −1732.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 349.7× | — |
| Net cash | $633.9M | $520.0M |
| Dividend yield | — | — |
| Volatility (60d) | 52.2% | 59.4% |
| Short % of float | 16.4% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).